The study of the prevalence of hyperprolactinemia among young women with menstrual disorders showed that hyperprolactinemia was a relatively common cause of secondary amenorrhea and equaled to 13.8% (18); our treatment significantly reduced and normalized PRL levels. This evidence concerns the gene PRL and Menstrual disorder.